The 10-second takeaway
For the quarter ended April 30 (Q2), Cooper Companies missed slightly on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue increased and GAAP earnings per share increased significantly.
Margins grew across the board.
Cooper Companies reported revenue of $344.6 million. The eight analysts polled by S&P Capital IQ anticipated sales of $350.0 million on the same basis. GAAP reported sales were 5.9% higher than the prior-year quarter's $325.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.12. The nine earnings estimates compiled by S&P Capital IQ predicted $1.20 per share. GAAP EPS of $1.12 for Q2 were 53% higher than the prior-year quarter's $0.73 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 64.0%, 200 basis points better than the prior-year quarter. Operating margin was 19.0%, 50 basis points better than the prior-year quarter. Net margin was 15.9%, 500 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $366.4 million. On the bottom line, the average EPS estimate is $1.29.
Next year's average estimate for revenue is $1.42 billion. The average EPS estimate is $5.05.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cooper Companies is outperform, with an average price target of $89.00.
The healthcare investing landscape is littered with also-rans and a few major winners. Is Cooper Companies the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.
- Add Cooper Companies to My Watchlist.